Zobrazeno 1 - 3
of 3
pro vyhledávání: '"E. Christine Siepl"'
Autor:
Jürgen Kratzsch, Mohamed El Kholy, Paul Saenger, Jin Hwa Lee, Rajesh Khadgawat, Vaman Khadilkar, Valentina Peterkova, Verónica Mericq, M Desai, Yoon Ju Bae, Elena Bolshova, Hyi-Jeong Ji, E. Christine Siepl, Prema Lopez, Klavdia A. Radjuk, Dieter Martin
Publikováno v:
The Journal of Clinical Endocrinology & Metabolism. 99:126-132
Sustained-release GH formulations may provide a strategy for improving treatment compliance and persistence in GH-deficient patients.The aim of the study was to examine efficacy and safety of LB03002, a sustained-release GH formulation for once-weekl
Autor:
Catalin Gavrila, Hyi-Jeong Ji, E. Christine Siepl, Christian J. Strasburger, Mihail Coculescu, Vera Popovic, Conrad Savoy, J. Roemmler, Beverly M. K. Biller, David M. Cook, Hyunji Ahn
Publikováno v:
The Journal of Clinical Endocrinology & Metabolism. 96:1718-1726
A sustained-release recombinant human GH formulation, LB03002, has been recently developed, with pharmacokinetics and pharmacodynamic activity appropriate for once-weekly administration. LB03002 is a long-acting GH that is administered once a week by
Autor:
Catalin Gavrila, Hyunji Ahn, J. Roemmler, David M. Cook, Beverly M. K. Biller, Mihail Coculescu, Hyi-Jeong Ji, Christian J. Strasburger, E. Christine Siepl, Conrad Savoy, Vera Popovic
Publikováno v:
Pituitary. 16(3)
The weekly sustained-release recombinant human GH formulation LB03002, showed beneficial effects in GH-deficient (GHD) adults in a previous 26-week double-blind study. Prior studies of long-acting GH preparations in adults have only been conducted fo